However, some cancer cells upregulate TRAIL-R expression, and we recently showed that this facilitates progression of KRAS-mutated cancers via cancer cell-autonomous Rac1 activation independently of FADD (von Karstedt et al., 2015). This evidence concerns the gene KRAS and cancer.